BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mathew S, Faheem M, Ibrahim SM, Iqbal W, Rauff B, Fatima K, Qadri I. Hepatitis C virus and neurological damage. World J Hepatol 2016; 8(12): 545-556 [PMID: 27134702 DOI: 10.4254/wjh.v8.i12.545] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Ochoa-Sanchez R, Tamnanloo F, Rose CF. Hepatic Encephalopathy: From Metabolic to Neurodegenerative. Neurochem Res 2021. [PMID: 34129161 DOI: 10.1007/s11064-021-03372-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Squarza S, Galli A, Cariati M, Alberici F, Bertolini V, Frediani F, Uggetti C. Magnetic resonance imaging in central nervous system vasculitis in a patient affected by crioglobulin-negative hepatitis C virus infection: A likely correlation. Neuroradiol J 2018;31:193-5. [PMID: 28735554 DOI: 10.1177/1971400917700437] [Reference Citation Analysis]
3 Bosoi CR, Vandal M, Tournissac M, Leclerc M, Fanet H, Mitchell PL, Verreault M, Trottier J, Virgili J, Tremblay C, Lippman HR, Bajaj JS, Barbier O, Marette A, Calon F. High-Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer's Disease. Hepatol Commun 2021;5:446-60. [PMID: 33681678 DOI: 10.1002/hep4.1609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Cunha LRD, Vieira DA, Giampietro YG, Gomes AD, Lopes de Faria CL Jr, Freire de Melo F, Teixeira R, Teixeira de Carvalho A, Oliveira LM, Filho OAM, Rocha GA, Maria de Magalhães Queiroz D, Neves FS, Silva LD. Interleukin-10 promoter gene polymorphisms are associated with the first major depressive episode in chronic hepatitis C patients. Clin Res Hepatol Gastroenterol 2019;43:417-26. [PMID: 30591371 DOI: 10.1016/j.clinre.2018.11.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Nocentini U. Can we offer more for cognitive impairment in patients with chronic hepatitis C? Arq Neuropsiquiatr 2020;78:319-20. [PMID: 32609192 DOI: 10.1590/0004-282X20200055] [Reference Citation Analysis]
6 Ferri C, Ramos-Casals M, Zignego AL, Arcaini L, Roccatello D, Antonelli A, Saadoun D, Desbois AC, Sebastiani M, Casato M. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmun Rev. 2016;15:1145-1160. [PMID: 27640316 DOI: 10.1016/j.autrev.2016.09.006] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 10.5] [Reference Citation Analysis]
7 Zahr NM. The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity. Front Aging Neurosci 2018;10:56. [PMID: 29623036 DOI: 10.3389/fnagi.2018.00056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
8 Saif A, Pick A. Polyneuropathy following COVID-19 infection: the rehabilitation approach. BMJ Case Rep 2021;14:e242330. [PMID: 34031091 DOI: 10.1136/bcr-2021-242330] [Reference Citation Analysis]
9 Boglione L, Lupia T, Cariti G, Di Perri G. Efficacy and safety of interferon-free regimens in patients affected by chronic hepatitis C and psychiatric disorders. J Infect Chemother 2020;26:18-22. [PMID: 31301972 DOI: 10.1016/j.jiac.2019.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Tharwa ES, Mohamed A, Elshazly H, Salama M, Youssef MI, Bakeer MS, Kamel SY, Abdelmageed SM, Shabana HS, Allam MA, Alshazly SM, Hamed EFA, Zied HY, Elwazzan D, Elkhadry SW, Mahros AM, Ahmed MH, Alwaseef MAA, Abdel-Samiee M. Sudomotor Changes in Hepatitis C Virus Infection with or without Diabetes Mellitus: A Pilot Study in Egyptian Patients. Am J Trop Med Hyg 2020. [PMID: 33245041 DOI: 10.4269/ajtmh.20-0612] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Chlilek A, Roger C, Muller L, Carles MJ, Stephan R, Laureillard D, Lavigne JP, Lefrant JY, Sotto A. Severe Guillain-Barré syndrome associated with chronic active hepatitis C and mixed cryoglobulinemia: a case report. BMC Infect Dis 2019;19:636. [PMID: 31315560 DOI: 10.1186/s12879-019-4278-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Singer EJ, Nemanim NM. The Persistence of HIV-Associated Neurocognitive Disorder (HAND) in the Era of Combined Antiretroviral Therapy (cART). In: Shapshak P, Levine AJ, Foley BT, Somboonwit C, Singer E, Chiappelli F, Sinnott JT, editors. Global Virology II - HIV and NeuroAIDS. New York: Springer; 2017. pp. 375-403. [DOI: 10.1007/978-1-4939-7290-6_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Gallach M, Vergara M, da Costa JP, Miquel M, Casas M, Sanchez-Delgado J, Dalmau B, Rudi N, Parra I, Monllor T, Sanchez-Lloansí M, Dosal A, Valero O, Calvet X. Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C. PLoS One 2018;13:e0208112. [PMID: 30566421 DOI: 10.1371/journal.pone.0208112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
14 Sohail MM. Belief in God's Help During Hepatitis C: A Qualitative Study on Muslim Patients in Pakistan. J Relig Health 2020;59:928-45. [PMID: 30229413 DOI: 10.1007/s10943-018-0700-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Lotz SK, Blackhurst BM, Reagin KL, Funk KE. Microbial Infections Are a Risk Factor for Neurodegenerative Diseases. Front Cell Neurosci 2021;15:691136. [PMID: 34305533 DOI: 10.3389/fncel.2021.691136] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Mpekoulis G, Tsopela V, Panos G, Siozos V, Kalliampakou KI, Frakolaki E, Sideris CD, Vassiliou AG, Sideris DC, Vassilacopoulou D, Vassilaki N. Association of Hepatitis C Virus Replication with the Catecholamine Biosynthetic Pathway. Viruses 2021;13:2139. [PMID: 34834946 DOI: 10.3390/v13112139] [Reference Citation Analysis]
17 Mapoure NY, Budzi MN, Eloumou SAFB, Malongue A, Okalla C, Luma HN. Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study. PLoS One. 2018;13:e0192406. [PMID: 29513678 DOI: 10.1371/journal.pone.0192406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
18 Adinolfi LE, Nevola R, Rinaldi L, Romano C, Giordano M. Chronic Hepatitis C Virus Infection and Depression. Clin Liver Dis 2017;21:517-34. [PMID: 28689590 DOI: 10.1016/j.cld.2017.03.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
19 Choi HY, Mai TH, Kim KA, Cho H, Ki M. Association between viral hepatitis infection and Parkinson's disease: A population-based prospective study. J Viral Hepat 2020;27:1171-8. [PMID: 32558154 DOI: 10.1111/jvh.13346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Chemello L, Cavalletto L, Ferrari S, Monaco S. Impact of direct acting antivirals (DAA) on neurologic disorders in chronic hepatitis C. Minerva Gastroenterol (Torino) 2021;67:234-43. [PMID: 34672486 DOI: 10.23736/S2724-5985.21.02865-5] [Reference Citation Analysis]
21 Widyadharma IPE, Dewi PR, Wijayanti IAS, Utami DKI. Pain related viral infections: a literature review. Egypt J Neurol Psychiatr Neurosurg 2020;56:105. [PMID: 33169060 DOI: 10.1186/s41983-020-00238-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Loftis JM, Taylor J, Hudson R, Firsick EJ. Neuroinvasion and cognitive impairment in comorbid alcohol dependence and chronic viral infection: An initial investigation. J Neuroimmunol 2019;335:577006. [PMID: 31325774 DOI: 10.1016/j.jneuroim.2019.577006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Faccioli J, Nardelli S, Gioia S, Riggio O, Ridola L. Neurological and psychiatric effects of hepatitis C virus infection. World J Gastroenterol 2021; 27(29): 4846-4861 [PMID: 34447230 DOI: 10.3748/wjg.v27.i29.4846] [Reference Citation Analysis]
24 Loftis JM, Valerio J, Taylor J, Huang E, Hudson R, Taylor-Young P, Chang M, Ho SB, Dieperink E, Miranda JL, Hauser P. S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder. Alcohol Clin Exp Res 2018. [PMID: 29953169 DOI: 10.1111/acer.13796] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
25 Moretti R, Giuffrè M, Merli N, Caruso P, Di Bella S, Tiribelli C, Crocè LS. Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders. Brain Sci 2021;11:1569. [PMID: 34942871 DOI: 10.3390/brainsci11121569] [Reference Citation Analysis]